Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alnylam Pharmaceuticals I...

    NASDAQ: ALNY · Real-Time Price · USD
    449.02
    6.29 (1.42%)
    At close: Aug 15, 2025, 3:59 PM
    448.91
    -0.02%
    After-hours: Aug 15, 2025, 04:10 PM EDT

    Alnylam Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.25B 1.83B 1.04B 844.29M
    Cost of Revenue
    		 323.37M 310.41M 168.82M 140.14M
    Gross Profit
    		 1.92B 1.52B 868.6M 704.14M
    Operating Income
    		 -176.88M -282.18M -785.07M -708.65M
    Interest Income
    		 121.99M 95.56M 24.81M 1.58M
    Pretax Income
    		 -377.38M -433.52M -1.13B -852.14M
    Net Income
    		 -278.16M -440.24M -1.13B -852.82M
    Selling & General & Admin
    		 975.53M 795.65M 770.66M 620.64M
    Research & Development
    		 1.13B 1B 883.01M 792.16M
    Other Expenses
    		 n/a n/a n/a -2.05M
    Operating Expenses
    		 2.1B 1.8B 1.65B 1.41B
    Interest Expense
    		 141.86M 121.22M 155.97M 143.02M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 2.43B 2.11B 1.82B 1.55B
    Income Tax Expense
    		 -99.22M 6.72M 4.16M 680K
    Shares Outstanding (Basic)
    		 127.65M 124.91M 121.69M 118.45M
    Shares Outstanding (Diluted)
    		 127.65M 124.91M 121.69M 118.45M
    EPS (Basic)
    		 -2.16 -3.52 -9.3 -7.2
    EPS (Diluted)
    		 -2.16 -3.52 -9.3 -7.2
    EBITDA
    		 -178.85M -258.24M -926.56M -661.56M
    EBIT
    		 -235.52M -312.3M -971.02M -709.12M
    Depreciation & Amortization
    		 56.67M 54.05M 44.47M 47.57M

    Add to Watchlist